BBSRC Portfolio Analyser

BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments: UKRI - What we have funded

Investigator / Supervisor details

NameDr Mark O'Connor
Current InstitutionKuDOS Pharmaceuticals Ltd
Current DepartmentKuDOS Pharmaceuticals Ltd
Previous Institutions

Current Awards

No current BBSRC awards

Completed Awards

ReferenceTitleAward RoleValue £Type
02/A2/C/08076 How does the apoptotic regulator Bcl-2 promote the survival of cells that have suffered DNA damage? Co-Supervisor 50,482 Studentships
terms and conditions of use (opens in new window)
export PDF file
back to list new search